Clinical Trial Update: Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessed the correlation between Florbetapir F-18 PET imaging and amyloid pathology in the brain for Alzheimer's disease; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-05-07